The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies, intended to strengthen regulatory understanding and provide practical support to developers in one of the fastest-growing areas of UK medtech.
The announcement, published on the MHRA's official blog, describes a coordinated effort to help innovators navigate regulatory expectations, improve compliance and bring safe, effective digital mental health products into clinical use. According to the agency, the initiative responds to growing demand for clarity on evidence requirements, post-market responsibilities and the regulatory landscape for software-based and AI-enabled mental health tools.
A forum for shared learning
The community is to bring together developers, clinicians, researchers, commissioners and regulatory specialists. As the field expands from therapeutic apps to AI-supported assessment tools, the MHRA says consistent, practical guidance has become more urgent.
Stated objectives include:
- helping developers interpret regulatory requirements and build compliance into product design earlier;
- identifying common challenges, particularly for small and medium-sized enterprises entering the mental health space;
- sharing real-world experience from organisations already working through regulatory pathways;
- strengthening dialogue between industry and regulators so emerging technologies meet expectations on safety, performance and evidence.
Survey to set priorities
To shape the community's initial priorities, the MHRA has opened a survey for developers and other stakeholders across the medtech ecosystem. It asks about current regulatory challenges, where clearer guidance is needed and how compliance support could be improved. The agency is seeking broad participation so that the group's work reflects real-world needs rather than top-down assumptions.
The announcement does not specify timing for the community's first meetings, the form its outputs will take, or how survey responses will be used. The MHRA frames participation as a route for developers to influence future regulatory support and to help create a more predictable, transparent environment for innovation.